CDC to Toughen COVID-19 Testing for International Travelers
WEDNESDAY, Dec. 1, 2021 (HealthDay News) — As the world struggles with ways to stem the spread of the new omicron variant, the U.S. Centers of Disease Control and Prevention announced Tuesday that international travelers to the United States will soo…
Learn MoreFDA Panel Mulls Merck COVID-19 Antiviral Pill
TUESDAY, Nov. 30, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel is meeting Tuesday to weigh both the safety and power of the new Merck antiviral pill in preventing severe COVID-19.There are already two strikes against the…
Learn MoreOld Spice, Secret Antiperspirants Recalled Due to Benzene
TUESDAY, Nov. 30, 2021 (HealthDay News) — Several Old Spice and Secret aerosol spray antiperspirants and hygiene products have been voluntarily recalled in the United States due to the presence of benzene, Proctor & Gamble says.Benzene exposure can o…
Learn MoreOmicron Variant Spurs New York Officials to Recommend Masking Indoors
TUESDAY, Nov. 30. 2021 (HealthDay News) — Amid growing concerns about the new omicron variant, New York Governor Kathy Hochul and New York City Health Commissioner Dave Chokshi, M.D., have advised all residents to wear masks while indoors.”Today, I a…
Learn MorePfizer to Seek FDA Approval of Boosters for Teens Ages 16 to 17
TUESDAY, Nov. 30, 2021 (HealthDay News) — Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16 to 17 years.Sources familiar with the matter told The New York Times that the U.S. Food a…
Learn MoreRegeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the omicron variant.The company noted that prior analyses sugg…
Learn MoreFDA Approves Imaging Drug That Can Help Surgeons Spot Ovarian Cancers
TUESDAY, Nov. 30, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved a new imaging drug that can help identify ovarian tumors during surgery.The drug, Cytalux (pafolacianine), is meant to improve a surgeon’s ability to d…
Learn MoreMerck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
MONDAY, Nov. 29, 2021 (HealthDay News) — Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administra…
Learn MoreBiden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
MONDAY, Nov. 29, 2021 (HealthDay News) — Vaccines and masks will be the United States’ first line of defense against the new omicron variant, not lockdowns or border closures, President Joe Biden told the nation Monday.
“If people are vaccinated and …
Vaccine Makers Already Testing Their Shots Against Omicron Variant
MONDAY, Nov. 29, 2021 (HealthDay News) — As concerns about the new omicron variant grow, vaccine makers say they are already working on ways to protect people against the potential new threat.Pfizer said it and its partner BioNTech could develop and …
Learn More